Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
Go back to Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 229.29 +10.59 (4.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.70 | 52 Week High | $89.18 | |||
| Open | $234.07 | 52 Week Low | $65.70 | |||
| Day High | $238.85 | P/E | 106.65 | |||
| Day Low | $224.28 | EPS | $2.15 | |||
| Volume | 1,075,121 | |||||
